Copyright
©The Author(s) 2015.
World J Cardiol. Nov 26, 2015; 7(11): 719-741
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.719
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.719
Vasoactive substances |
Endothelium-derived vasodilators |
Adrenomedullin |
Endothelium-derived hyperpolarizing factors |
Kinins |
Nitric oxide |
Prostacyclin |
Endothelium-derived vasoconstrictors |
Angiotensin II |
Endothelin-1 |
Vasoconstrictor prostanoids |
Coagulation and fibrinolysis |
Coagulation |
Factor V |
Heparan sulfate |
Protein C |
Protein S |
Thrombomodulin |
Tissue factor |
von Willebrand factor |
Fibrinolysis |
Plasminogen activator inhibitor |
Tissue plasminogen activator |
Urokinase |
Growth factors |
Basic fibroblast growth factor |
Insulin-like growth factor |
Platelet-derived growth factor |
Transforming growth factor |
Inflammatory and immunological mediators |
Cytokines |
Interleukins |
Monocyte chemoattractant protein 1 |
Transforming growth factor |
Tumor necrosis factor-α |
Adhesion molecules |
Intercellular adhesion molecules |
Platelet-endothelial cell adhesion molecules |
Selectins |
Vascular cell adhesion molecules |
Reactive oxygen species and reactive nitrogen species |
Reactive oxygen species |
Hydrogen peroxide (H2O2) |
Hydroperoxyl (HO2) |
Superoxide (O2-) |
Reactive nitrogen species |
Nitrite (NO2-) |
Nitrogen dioxide (NO2) |
Peroxynitrite (ONOO-) |
Nitryl chloride (NO2Cl) |
- Citation: Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol 2015; 7(11): 719-741
- URL: https://www.wjgnet.com/1949-8462/full/v7/i11/719.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i11.719